<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00129766</url>
  </required_header>
  <id_info>
    <org_study_id>MI-CP110</org_study_id>
    <nct_id>NCT00129766</nct_id>
  </id_info>
  <brief_title>Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children</brief_title>
  <official_title>A Pivotal Phase 3 Study of MEDI-524 (Numax; Motavizumab), an Enhanced Potency Humanized RSV Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedImmune LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedImmune LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study was to compare the safety and efficacy of motavizumab to
      palivizumab when administered monthly by intramuscular (IM) injection for the reduction of
      the incidence of RSV hospitalization among children at high risk for serious RSV disease. A
      secondary objective was to compare the incidence of medically-attended lower respiratory
      infections (LRIs) between treatment groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, double-blind, palivizumab-controlled, multi-center, multi-national trial
      conducted during 2 Northern Hemisphere RSV seasons with an intervening season in the Southern
      Hemisphere. Each child only participated during a single RSV season. Approximately 6,600
      children at risk for serious RSV disease were to be randomized in a 1:1 ratio to receive
      either 15 mg/kg of palivizumab or motavizumab by IM injection every 30 days for a total of 5
      doses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">May 2006</completion_date>
  <primary_completion_date type="Actual">May 2006</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of RSV Hospitalization (Includes Deaths by RSV)</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>RSV hospitalization was defined as 1) a respiratory hospitalization with a positive RSV test (primary), 2) a new onset of lower respiratory symptoms in an already hospitalized child, with an objective measure of worsening respiratory status and positive RSV test (nosocomial), or 3) death demonstrated to have been caused by RSV (by autopsy or clinical history and virologic evidence).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting Any Adverse Events (AEs)</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>Number of participants reporting one or more AEs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting Any Related AEs</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>Number of participants reporting one or more AEs considered related to study drug by the investigator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting Any Serious Adverse Events (SAEs)</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>Number of participants reporting one or more SAEs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting Any Related SAEs</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>Number of participants reporting one or more SAEs considered related to study drug by the investigator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting AEs by Highest Severity Grade</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>Adverse events events were graded by severity; Level 1, 2, 3, or 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Discontinued Study Drug Due to AEs</measure>
    <time_frame>Days 0 - 150</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Died</measure>
    <time_frame>Days 0 - 150</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting Changes in Vital Signs From Baseline</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>Vital signs that were in a higher toxicity grade than observed at baseline were to be recorded as AEs</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Incidence of Outpatient Medically-attended Lower Respiratory Illness (LRI)</measure>
    <time_frame>Day 0 - 150</time_frame>
    <description>LRI was defined as an event of bronchiolitis or pneumonia or the occurance of a lower tract infectious illness as determined by the PI based on medical history, signs, and symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Incidence of RSV-specific Medically-attended Outpatient Lower Respiratory Illnesses (LRIs) Between Treatment Groups</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>The RSV-specific LRI was defined as an outpatient medically-attended LRI associated with a positive RSV test and was not inclusive of events that required hospitalization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Incidence of Medically-attended Otitis Media (OM) Infections</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>Otitis media (OM) was to be recorded as the diagnosis if the following terms were used by the medical care provider: acute OM, acute tympanic membrane (TM) perforation, bulging TM, red TM with fever, OM with effusion, or middle ear effusion. A new episode was defined as a physician-diagnosed OM in either ear after a normal middle ear exam of the ear in question or an episode of acute OM greater than or equal to 21 days after resolution of the previous episode. A diagnosis of persistent middle ear effusion was not to be recorded as a new OM event.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Frequency of Prescribed Antibiotics for Medically-attended LRI</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>The average number of presciptions per event per subject was summarized for each treatment group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Frequency of Prescribed Antibiotics for Medically-attended OM Infections</measure>
    <time_frame>Days 0 - 150</time_frame>
    <description>The average number of presciptions per event per subject was summarized for each treatment group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Number of Participants With Anti-motavizumab Antibodies</measure>
    <time_frame>Day 0 - 120</time_frame>
    <description>Detection of anti-motavizumab antibodies was defined as a titer with a dilution value equal to or greater than 1:10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Serum Concentrations of Motavizumab at Day 0</measure>
    <time_frame>Day 0</time_frame>
    <description>Mean serum concentrations of motavizumab at Day 0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 1</measure>
    <time_frame>30 days post Dose 1</time_frame>
    <description>Mean serum concentrations of motavizumab at 30 days post Dose 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 2</measure>
    <time_frame>30 days post Dose 2</time_frame>
    <description>Mean serum concentrations of motavizumab at 30 days post Dose 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 3</measure>
    <time_frame>30 days post Dose 3</time_frame>
    <description>Mean serum concentrations of motavizumab at 30 days post Dose 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 4</measure>
    <time_frame>30 days post Dose 4</time_frame>
    <description>Mean serum concentrations of motavizumab at 30 days post Dose 4</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6635</enrollment>
  <condition>Respiratory Syncytial Virus Infections</condition>
  <arm_group>
    <arm_group_label>palivizumab</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 mg/kg administered intramuscularly for 5 monthly doses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>motavizumab (MEDI-524)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 mg/kg of motavizumab was administered intramuscularly for 5 monthly doses</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>motavizumab (MEDI-524)</intervention_name>
    <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
    <arm_group_label>motavizumab (MEDI-524)</arm_group_label>
    <other_name>MEDI-524</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>palivizumab</intervention_name>
    <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
    <arm_group_label>palivizumab</arm_group_label>
    <other_name>Synagis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  24 months of age or younger at randomization (child must be randomized on or before
             his/her 24-month birthday) with a diagnosis of chronic lung disease (CLD) of
             prematurity requiring medical intervention/management (i.e., supplemental oxygen,
             bronchodilators, or diuretics) within 6 months before randomization

        OR:

          -  35 weeks gestational age or less at birth and 6 months of age or younger at
             randomization (children were to be randomized on or before his/her 6-month birthday)

        Exclusion Criteria:

          -  Hospitalization at the time of randomization (unless discharge was anticipated within
             10 days)

          -  Mechanical ventilation or other mechanical support (including continuous positive
             airways pressure [CPAP])

          -  Life expectancy &lt; 6 months

          -  Active RSV infection (a child with signs/symptoms of respiratory infection must have
             had negative RSV testing)

          -  Known renal impairment

          -  Known hepatic dysfunction

          -  Chronic seizure or evolving or unstable neurologic disorder

          -  Congenital heart disease [CHD] (children with uncomplicated CHD [e.g., patent ductus
             arterious (PDA), small septal defect] and children with complicated CHD that were
             currently anatomically and hemodynamically normal could be enrolled)

          -  Known immunodeficiency

          -  Mother with HIV infection (unless the child has been proven to be not infected)

          -  Known allergy to Ig products

          -  Receipt of palivizumab, RSV-IGIV, or other RSV-specific monoclonal antibody, or any
             other polyclonal antibody (for example, hepatitis B IG, IVIG, VZIG) within 3 months
             prior to randomization

          -  Anticipated use of palivizumab or IVIG during the study (blood transfusions permitted)

          -  Previous receipt of RSV vaccines

          -  Participation in other investigational drug product studies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M Pamela Griffin, MD</last_name>
    <role>Study Director</role>
    <affiliation>MedImmune LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Of Alabama At Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alabama Neonatal Medicine OC</name>
      <address>
        <city>Pike Road</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maricopa Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Arkansas Pediatric Clinic, PA</name>
      <address>
        <city>Benton</city>
        <state>Arkansas</state>
        <zip>72015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Children's Clinic Of Jonesboro, P.A.</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Children's Hospital Research Institute</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Pediatric Clinic</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Little Rock Children's Clinic, PA</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miller Children's Hospital</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Health Care Plan</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Orange County</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Clara Valley Medical Center</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95728</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connecticut Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric Pulmonology, LLC</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06920</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A. I. Dupont Hospital For Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georgetown University Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shands Hospital At The University Of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Nemours Children's Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Miami Medical Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic Biomedical Research</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. S. Florida Pediatrics Ambulatory Care Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University School Of Medicine</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georgia Pediatric Pulmonology Associates</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Medical College Of Georgia</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kapiolani Medical Center for Woman and Children</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96826</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocate Hope Children's Hospital</name>
      <address>
        <city>Cook</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lutheran General Children's Hospital</name>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James Whitcomb Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital of South Bend</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Louisiana State University MidCity Clinic</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tulane Hospital for Children</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Maryland School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts-New England Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Mott Children's Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Of Michigan</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John Hospital &amp; Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DeVos Children's Hospital</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Duluth Clinic</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare D.B.A. Hospitals &amp; Clinics</name>
      <address>
        <city>St. Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center Pediatric</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Lung Specialist, Ltd</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth Medical School</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Barnabas Medical Center</name>
      <address>
        <city>Livingston</city>
        <state>New Jersey</state>
        <zip>07039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Jersey Medical School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bronx-Lebanon Hospital Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10457</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jacobi Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Brooklyn Hospital Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women &amp; Children's Hospital</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14222</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schneider Children's Hospital</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Children's Medical Group</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12603</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital State University of New York at Stony Brook Department of Pediatrics</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Crouse Hospital NICU</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina-School of Medicine</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Carolina University School of Medicine</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27858</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Raleigh Pediatric Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University School of Medicine</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Medical Center Of Akron</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beehly Medical Park Women's and Children's Pav.</name>
      <address>
        <city>Boardman</city>
        <state>Ohio</state>
        <zip>44512</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Col. of Med.</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metro Health Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric Clinical Trials International, Inc.</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Medical Center</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tod Children's Hospital</name>
      <address>
        <city>Mahaning</city>
        <state>Ohio</state>
        <zip>44501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toledo Children's Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104-5066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Francis Hospital EOPC</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health Sciences University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bryn Mawr Hospital</name>
      <address>
        <city>Bryn Mawr</city>
        <state>Pennsylvania</state>
        <zip>19010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center- JW Children's Hospital</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital Of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jefferson-duPont Children's Health Program</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MUSC</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sioux Valley Hospital University of South Dakota Medical Center</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lebonheur Children's Medical Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Driscoll Children's Hospital</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78411</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. Of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Texas Houston Medical School</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Tech Health Sciences Center</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79415</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Texas Health Science Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott &amp; White Memorial Hospital</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primary Children's Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>85113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Hospital</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VCU Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Physicians</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Clinic</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waukesha Memorial Hospital, Inc</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Corporate Center</name>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Peiade Interzonal General de Augodos</name>
      <address>
        <city>Buenos Aires</city>
        <zip>B1754FWE</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General De Ninos Pedro De Elizalde</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1270AAN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanatorio Trinidad</name>
      <address>
        <city>Capital Federal</city>
        <zip>C145AIN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Materno Neonatal</name>
      <address>
        <city>Cordoba</city>
        <zip>C5000BJH</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Canberra Hospital</name>
      <address>
        <city>Garran</city>
        <state>Australian Capital Territory</state>
        <zip>2605</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Hunter Children's Hospital</name>
      <address>
        <city>New Lambton</city>
        <state>New South Wales</state>
        <zip>2305</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital (Brisbane)</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Clinical Research Centre</name>
      <address>
        <city>Kippa-Ring</city>
        <state>Queensland</state>
        <zip>4021</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mater Mothers Hospital Raymond Terrace</name>
      <address>
        <city>South Brisbane</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Hobart Hospital</name>
      <address>
        <city>Hobart</city>
        <state>Tasmania</state>
        <zip>7000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital (Melbourne)</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Children's Hospital</name>
      <address>
        <city>Subiaco</city>
        <state>Western Australia</state>
        <zip>6008</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's and Children's Hospital</name>
      <address>
        <city>North Adelaide</city>
        <zip>5006</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinik fur Kinder und Jugenheilkunde, Graz</name>
      <address>
        <city>Graz</city>
        <zip>A-8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LandesKrankenHaus Tulln, Kinderabteilung</name>
      <address>
        <city>Tulln</city>
        <zip>A-3430</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemeines KrankenHaus Universitatsklinkiken Wein</name>
      <address>
        <city>Wien</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SMZ-Ost Donauspital Wien</name>
      <address>
        <city>Wien</city>
        <zip>A-1220</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital e Maternidade Celso Pierro-Puccamp</name>
      <address>
        <city>Campinas</city>
        <zip>13059-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mernidade Nossa Senhora De Fatima</name>
      <address>
        <city>Curitiba</city>
        <zip>80010-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital De Clinicas Da UFPR</name>
      <address>
        <city>Curitiba</city>
        <zip>80060-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sao Lucas da PUC-RS de Riberiao Perto da Universidade de Sao Paulo</name>
      <address>
        <city>Porto Alegre</city>
        <zip>90610-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Das Clinicas Da Faculdade De Medicina</name>
      <address>
        <city>Ribeirao Preto</city>
        <zip>14048-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericordia de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01221-020</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital e Maternidade Santa Marina</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04378-500</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Universidade de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05508-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multifunctional Hospital for Active Treatment &quot;Pleven&quot;</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Multifunctional Hospital for Active Treatment &quot;St. George&quot; Neonatology Clinic</name>
      <address>
        <city>Plovdiv</city>
        <zip>4000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Multifunctional Hospital for Active Treatment &quot;St. George&quot; Clinic of Pediatrics</name>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multifunctional Hospital for Active Treatment - Plovdiv</name>
      <address>
        <city>Plovdiv</city>
        <zip>4003</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Hospital of Pulmonary Diseases</name>
      <address>
        <city>Rousse</city>
        <zip>7004</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital for Active Treatment of Cardio-vascular Diseases</name>
      <address>
        <city>Sofia</city>
        <zip>1309</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital for Active Treatment of Obstetrics and Gynaecology&quot;-&quot;Maichin Dom&quot;</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital for Active Treatment of Pediatric Diseases</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Multifunctional Hospital for Active Treatment &quot;St. Marina&quot;</name>
      <address>
        <city>Varna</city>
        <zip>9010</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alberta Children's Hospital</name>
      <address>
        <city>Calgary</city>
        <zip>T2T 5C7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Charlottetown</city>
        <zip>PE C1A 8T5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Alberta/Stollery Children's Hospital</name>
      <address>
        <city>Edmonton</city>
        <zip>AB T6G 2J3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dalhousie University IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mcmaster Children's Hospital</name>
      <address>
        <city>Hamilton</city>
        <zip>L8S 4J9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre Monteal Children's Hospital</name>
      <address>
        <city>Montreal</city>
        <zip>H3H 1P3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sainte Justine Hospital</name>
      <address>
        <city>Montreal</city>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Eastern Ontario</name>
      <address>
        <city>Ottawa</city>
        <zip>K1H 8L1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de L'Universite Laval</name>
      <address>
        <city>Quebec City</city>
        <zip>G1V 4G2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal University Hospital</name>
      <address>
        <city>Saskatoon</city>
        <zip>STN 0W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's And Women's Hospital of BC</name>
      <address>
        <city>Vancouver</city>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Victoria General Hospital</name>
      <address>
        <city>Victoria</city>
        <zip>V8Z 6R5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Windsor Regional Hospital</name>
      <address>
        <city>Windsor</city>
        <zip>N8W 1L9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manitoba Institute Of Child Health University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <zip>R3E 3P4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital San Jose</name>
      <address>
        <city>Independencia</city>
        <zip>1196</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico de la Universidad de Chile</name>
      <address>
        <city>Independencia</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Dr. Sotero Del Rio</name>
      <address>
        <city>Puente Alto</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Dr. Feliz Buines Cerda</name>
      <address>
        <city>Quinta Normal</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Borja Arriaran</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Padre Hurtado</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemocnice CB</name>
      <address>
        <city>Ceske Budejovice</city>
        <zip>370 87</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FN Hradec Kralove Detska klinika</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>500 05</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemocnice s poliklinikou v Moste</name>
      <address>
        <city>Most</city>
        <zip>434 64</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice</name>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FNsP Ostrava</name>
      <address>
        <city>Ostrava</city>
        <zip>708 52</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FN Plzen</name>
      <address>
        <city>Plzen-Bory</city>
        <zip>305 99</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FN Plzen</name>
      <address>
        <city>Plzen-Lochotin</city>
        <zip>304 60</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vfn 1.Lf Uk</name>
      <address>
        <city>Praha 2</city>
        <zip>128 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni Thomayerova nemocnice S poliklinkou</name>
      <address>
        <city>Praha 4</city>
        <zip>140 59</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ustav pro peci o matku a dite</name>
      <address>
        <city>Praha 4</city>
        <zip>143 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FN Motol Novorozenecke oddeleni</name>
      <address>
        <city>Praha 5</city>
        <zip>150 06</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Batova krajska nemocnice Zlin</name>
      <address>
        <city>Zlin</city>
        <zip>762 75</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paediatrisk Afdeling Herning Centralsygehus</name>
      <address>
        <city>Herning</city>
        <zip>7400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hillerod Sygehus Helsevej 2</name>
      <address>
        <city>Hillerod</city>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hvidovre Hospital</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sygehus Viborg</name>
      <address>
        <city>Viborg</city>
        <zip>8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Medecine Neonatale et de reanimation pediatrique</name>
      <address>
        <city>Amiens Cedex 1</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Besancon-Hopital Saint-Jacques</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux/Hopital des enfants/Unite de Neonatologie B</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Chambery</name>
      <address>
        <city>Chambery</city>
        <zip>BP1125</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Jeanne de Flandre</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier/Hoptial Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes/Hospital Mere-Enfant</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHI Poissy/St Germain en Laye</name>
      <address>
        <city>Poissy Cedex</city>
        <zip>78300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Rennes/Hopital Sud</name>
      <address>
        <city>Rennes Cedex</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen Cedex</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Pierre Haute</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse-Hopital des Enfants</name>
      <address>
        <city>Toulouse Cedex 9</city>
        <zip>BP 3119</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Pediatrique Gatien de Clocheville</name>
      <address>
        <city>Tours Cedex</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruhr-Uni St. Josef Hospital</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Duisburg, Wedau Kliniken</name>
      <address>
        <city>Duisburg</city>
        <zip>47055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uni-Kinderklinik</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik fur Kinder und Jugendliche</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum Klinische Studien/Universtatsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universtatsklinikum Gottingen</name>
      <address>
        <city>Gottingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wittenberg/Zentrum: fur Kinderheilkunde, Universitatsklinik und Poliklinik fur Kinder and Jugendmedizin</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stiftung Hannoversche</name>
      <address>
        <city>Hannover</city>
        <zip>30173</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Im Neuenheimer Feld 153</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik und Jugendiche der Universitat Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatskinderlinik/Zentrum Fur klinische Studien</name>
      <address>
        <city>Mainz</city>
        <zip>55101</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklinik und Kinderpoliklinik</name>
      <address>
        <city>Muenchen</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stadtisches Krankenhaus Muchen-Harlaching</name>
      <address>
        <city>Munchen</city>
        <zip>81545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelischisches Krankenhaus</name>
      <address>
        <city>Oberhausen</city>
        <zip>46047</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenberg</name>
      <address>
        <city>Oldenberg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Rosenheim</name>
      <address>
        <city>Rosenheim</city>
        <zip>83022</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Kinderklinik Sankt Augustin GmbH</name>
      <address>
        <city>Sankt Augustin</city>
        <zip>53757</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;P&amp;A Kyriakou&quot; Children's hospital</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aghia Sofia Children hospital</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aristotele University of Thessaloniki, General &quot;AXEPA&quot; Hospital</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54636</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hippokration Hospital, University of Thessaloniki</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54642</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General hospital &quot;Papageorgiou&quot;</name>
      <address>
        <city>Thessaloniki</city>
        <zip>56429</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis Univ.</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <zip>1088</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schopf-Merei Agost Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>1092</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis Univ.</name>
      <address>
        <city>Budapest</city>
        <zip>1094</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DEOEC Neonatology Division</name>
      <address>
        <city>Debrecen</city>
        <zip>4012</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DEOEC, Dept. of Pediatry</name>
      <address>
        <city>Debrecen</city>
        <zip>4012</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Petz Aladar Teaching Hospital</name>
      <address>
        <city>Gyor</city>
        <zip>9023</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Borsod-Abaj-Zempln Megyei nkormnyzat Krhza</name>
      <address>
        <city>Miskolc</city>
        <zip>3501</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Josa Andras Hospital</name>
      <address>
        <city>Nyiregyhaza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pecs</name>
      <address>
        <city>Pecs</city>
        <zip>7623</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. of Pecs</name>
      <address>
        <city>Pecs</city>
        <zip>7624</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Csolnoky Ferenc Hospital</name>
      <address>
        <city>Veszprem</city>
        <zip>8200</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's hospital, Landspitali University Hospital</name>
      <address>
        <city>Reykjavik</city>
        <zip>101</zip>
        <country>Iceland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HaEmek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <zip>78306</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soroka Medical Center</name>
      <address>
        <city>Beer-Sheva</city>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bnei Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31048</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>34362</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wolfson Medical Center</name>
      <address>
        <city>Holon</city>
        <zip>58100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Ein-Kerem Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapir Medical Center</name>
      <address>
        <city>Kfar-Saba</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Laniado Medical Center</name>
      <address>
        <city>Natanya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schneider Medical Center</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rehovot</city>
        <zip>76100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sourasky Medical Center (Ichilov)</name>
      <address>
        <city>Tel-Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Tel-Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Poria Medical Center</name>
      <address>
        <city>Tiberia</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presio Ospedaliero di Alta Specializzazione &quot;G. Salesi&quot; - Azienda Ospedaliera Universitaria - Ospedali Riuniti &quot;Umberto I - G.M. Lancisi - G. Salesi&quot;</name>
      <address>
        <city>Ancona</city>
        <zip>60123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedali Riuniti di Bergamo - Azienda Ospedaliera/Unit Operativa di Patologia Neonatale</name>
      <address>
        <city>Bergamo</city>
        <zip>24128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Bologna - Policlinico S. Orsola - Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40139</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Generale di Bolzano</name>
      <address>
        <city>Bolzano</city>
        <zip>39100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Croce e Carle</name>
      <address>
        <city>Cuneo</city>
        <zip>12100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria</name>
      <address>
        <city>Foggia</city>
        <zip>71100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda USL di Imola - Ospedale di Imola</name>
      <address>
        <city>Imola</city>
        <zip>40026</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Alessandro Manzoni Lecco - Presidio dell'Azienda Ospedaliera &quot;Ospedale di Lecco&quot;</name>
      <address>
        <city>Lecco</city>
        <zip>23900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Policlinico Gaetano Martino</name>
      <address>
        <city>Messina</city>
        <zip>98100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Gerardo</name>
      <address>
        <city>Monza</city>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Parma</name>
      <address>
        <city>Parma</city>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Pisana - Ospedale S. Chiara</name>
      <address>
        <city>Pisa</city>
        <zip>56100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Sanitaria Ospedaliera O.I.R.M.-S. Anna</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Maria della Misericordoa Struttura Operativa Complessa di Patologia Neonatale e terapia Intesiva Neonatale</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Middlemore Hospital</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dunedin Hospital</name>
      <address>
        <city>Dunedin</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waikato Hospital</name>
      <address>
        <city>Hamilton</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palmerston North Hospital</name>
      <address>
        <city>Palmerston North</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Neonatologii AM w Biaymstoku</name>
      <address>
        <city>Biaystok</city>
        <zip>15-274</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Zakad Opieki Zdrowotnej Wojewdzki Szpital im. dr Jana Biziela w Bydgoszczy, Oddzia Noworodkw, Wczeniakw I Intensywnej Terapii Noworodka</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-168</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzia Pediatrii i Kardiologii z pododdziaem Patologii Noworodka</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-667</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewdzki Szpital Specjalistyczny, Oddzia Dziecicy</name>
      <address>
        <city>Czstochowa</city>
        <zip>42-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny nr 1, Klinika Neonatologii</name>
      <address>
        <city>Gdask</city>
        <zip>80-952</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Morski im. PCK, Oddzia Dziecicy</name>
      <address>
        <city>Gdynia</city>
        <zip>81-519</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Kliniczny Kliniki Neonatologii Szpitala Uniwersyteckiego w Krakowie</name>
      <address>
        <city>Krakow</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niepubliczny Zakad Opieki Zdrowotnej Salmed s.c.</name>
      <address>
        <city>Leczna</city>
        <zip>21-010</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dziecicy Szpital Kliniczny im. Prof. dr hab. n. med. Antoniego Gbali w Lublinie</name>
      <address>
        <city>Lublin</city>
        <zip>20-093</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Neonatologii AM w Poznaniu</name>
      <address>
        <city>Pozna</city>
        <zip>60-535</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>II Klinika Chorb Dzieci PAM, Samodzielny Publiczny</name>
      <address>
        <city>Szczecin</city>
        <zip>71-252</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Neonatologii AM w Warszawie</name>
      <address>
        <city>Warsaw</city>
        <zip>00-315</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Niemowlca, Instytut Pomnik - Centrum Zdrowia Dziecka</name>
      <address>
        <city>Warszawa</city>
        <zip>04-736</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny nr 4 im.M.Konopnickiej, Oddzia Intensywnej Terapii i Anestezjologii</name>
      <address>
        <city>d</city>
        <zip>91-738</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Neonatologii, Instytut Centrum Zdrowia Matki Polki</name>
      <address>
        <city>d</city>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric City Hospital #13</name>
      <address>
        <city>Moscow</city>
        <zip>103001</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morozovsky Pediatric City Hospital</name>
      <address>
        <city>Moscow</city>
        <zip>117049</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Smolensk State Medical Academy</name>
      <address>
        <city>Smolensk</city>
        <zip>214018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg City Outpatient Hospital #45</name>
      <address>
        <city>St. Petersburg</city>
        <zip>193312</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Petersburg State Pediatric Medical Academy</name>
      <address>
        <city>St. Petersburg</city>
        <zip>194100</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Petersburg State Pediatric Medical Academy</name>
      <address>
        <city>St. Petersburg</city>
        <zip>194100</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pediatric City Hospital #1</name>
      <address>
        <city>St. Petersburg</city>
        <zip>198205</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic y Maternistat - Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sant Joan de Du (Barcelona)</name>
      <address>
        <city>Barcelona</city>
        <zip>08950</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Cruces</name>
      <address>
        <city>Cruces</city>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Reina Sofia</name>
      <address>
        <city>Crdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Josep Trueta</name>
      <address>
        <city>Gerona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Donostia (San Sebastian)</name>
      <address>
        <city>Guipuzcoa</city>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Materno Infantil deJan</name>
      <address>
        <city>Jan</city>
        <zip>23007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General de Jerez</name>
      <address>
        <city>Jerez</city>
        <zip>11407</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Juan Canalejo</name>
      <address>
        <city>La Corua</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Materno Infantil de Canarias</name>
      <address>
        <city>Las Palmas de Gran Canaria</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clnico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz- Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Severo Ochoa</name>
      <address>
        <city>Madrid</city>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Materno Infantil/Neumologa peditrica</name>
      <address>
        <city>Malaga</city>
        <zip>29011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <zip>38320</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Santiago</name>
      <address>
        <city>Santiago de Compostela</city>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Maternal Virgen del Roco</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41071</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Joan XXIII</name>
      <address>
        <city>Tarragona</city>
        <zip>43007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Fe Maternidad</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Xeral-Ces</name>
      <address>
        <city>Vigo</city>
        <zip>36204</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mlarsjukhuset</name>
      <address>
        <city>Eskilstuna</city>
        <zip>631 88</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Queen Silvia Children's Hospital</name>
      <address>
        <city>Goteborg</city>
        <zip>41685</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital Solna</name>
      <address>
        <city>Stockholm</city>
        <zip>171 76</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danderyds Sjukhus</name>
      <address>
        <city>Stockholm</city>
        <zip>182 88</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>751 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hacettepe niversitesi hsan Doramac ocuk Hastanesi Neonatoloji nitesi</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ankara niversitesi</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ege niversitesi Tp Fakltesi</name>
      <address>
        <city>Izmir</city>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dokuz Eyll niversitesi Tp Fakltesi</name>
      <address>
        <city>Izmir</city>
        <zip>35340</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Heartlands Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dumfries and Galloway Royal Infirmary</name>
      <address>
        <city>Dumfries</city>
        <zip>DG1 4AP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Respiratory Medicine Division of Maternal and Child Health Sciences Ninewells Hospital</name>
      <address>
        <city>Dundee</city>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medway Maritime Hospital</name>
      <address>
        <city>Gillingham Kent</city>
        <zip>ME7 5NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Anne Hospital</name>
      <address>
        <city>Hants</city>
        <zip>SO16 5YA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Claredon Wing, Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <zip>LS2 9NS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St James' University Hospital</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesborough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen's Medical Centre Nottingham University Hospital</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheffield Children's Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S10 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Hampshire County Hospital</name>
      <address>
        <city>Winchester</city>
        <zip>SO22 5DG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Iceland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Carbonell-Estrany X, Simes EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA; Motavizumab Study Group. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics. 2010 Jan;125(1):e35-51. doi: 10.1542/peds.2008-1036. Epub 2009 Dec 14.</citation>
    <PMID>20008423</PMID>
  </results_reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2005</study_first_submitted>
  <study_first_submitted_qc>August 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2005</study_first_posted>
  <results_first_submitted>June 21, 2013</results_first_submitted>
  <results_first_submitted_qc>June 21, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 28, 2013</results_first_posted>
  <last_update_submitted>June 21, 2013</last_update_submitted>
  <last_update_submitted_qc>June 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Respiratory Syncytial Virus (RSV)</keyword>
  <keyword>motavizumab</keyword>
  <keyword>palivizumab</keyword>
  <keyword>Synagis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Virus Diseases</mesh_term>
    <mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Palivizumab</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 6,635 children were randomized in a 1:1 ratio at 347 centers in 24 countries within the Northern and Southern hemispheres between 01/Nov/2004 and 09/Dec/2005; each child participated in the study for a single RSV season.</recruitment_details>
      <pre_assignment_details>Randomization was blocked by study site and stratified according to presence/absence of CLD of prematurity requiring medical intervention/management.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Palivizumab</title>
          <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
        </group>
        <group group_id="P2">
          <title>Motavizumab</title>
          <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3306"/>
                <participants group_id="P2" count="3329"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3246"/>
                <participants group_id="P2" count="3270"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal of consent</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Palivizumab</title>
          <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
        </group>
        <group group_id="B2">
          <title>Motavizumab</title>
          <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3306"/>
            <count group_id="B2" value="3329"/>
            <count group_id="B3" value="6635"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.98" spread="3.78"/>
                    <measurement group_id="B2" value="3.99" spread="3.75"/>
                    <measurement group_id="B3" value="3.99" spread="3.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1495"/>
                    <measurement group_id="B2" value="1513"/>
                    <measurement group_id="B3" value="3008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1811"/>
                    <measurement group_id="B2" value="1816"/>
                    <measurement group_id="B3" value="3627"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1130"/>
                    <measurement group_id="B2" value="1167"/>
                    <measurement group_id="B3" value="2297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Greece</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="191"/>
                    <measurement group_id="B2" value="181"/>
                    <measurement group_id="B3" value="372"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Turkey</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Russian Federation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="301"/>
                    <measurement group_id="B2" value="305"/>
                    <measurement group_id="B3" value="606"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chile</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="87"/>
                    <measurement group_id="B3" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="90"/>
                    <measurement group_id="B3" value="179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="189"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="111"/>
                    <measurement group_id="B3" value="218"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hungary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="198"/>
                    <measurement group_id="B2" value="192"/>
                    <measurement group_id="B3" value="390"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Czech Republic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="171"/>
                    <measurement group_id="B2" value="177"/>
                    <measurement group_id="B3" value="348"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="134"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="266"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Argentina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="106"/>
                    <measurement group_id="B2" value="105"/>
                    <measurement group_id="B3" value="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bulgaria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="95"/>
                    <measurement group_id="B2" value="101"/>
                    <measurement group_id="B3" value="196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Iceland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="131"/>
                    <measurement group_id="B2" value="122"/>
                    <measurement group_id="B3" value="253"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Zealand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of RSV Hospitalization (Includes Deaths by RSV)</title>
        <description>RSV hospitalization was defined as 1) a respiratory hospitalization with a positive RSV test (primary), 2) a new onset of lower respiratory symptoms in an already hospitalized child, with an objective measure of worsening respiratory status and positive RSV test (nosocomial), or 3) death demonstrated to have been caused by RSV (by autopsy or clinical history and virologic evidence).</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of RSV Hospitalization (Includes Deaths by RSV)</title>
          <description>RSV hospitalization was defined as 1) a respiratory hospitalization with a positive RSV test (primary), 2) a new onset of lower respiratory symptoms in an already hospitalized child, with an objective measure of worsening respiratory status and positive RSV test (nosocomial), or 3) death demonstrated to have been caused by RSV (by autopsy or clinical history and virologic evidence).</description>
          <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3306"/>
                <count group_id="O2" value="3329"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>ITT population</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Confidence interval and relative risk adjusted for the stratification factor of presence or absence of CLD of prematurity as specified on the CRF.</non_inferiority_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.740</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.503</ci_lower_limit>
            <ci_upper_limit>1.083</ci_upper_limit>
            <estimate_desc>Relative risk was calculated as (Pn/Ps) where Pn is the proportion of patients with RSV hospitalization in the motavizumab group and Ps is the proportion of patients with RSV hospitalization in the palivizumab group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting Any Adverse Events (AEs)</title>
        <description>Number of participants reporting one or more AEs</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Any Adverse Events (AEs)</title>
          <description>Number of participants reporting one or more AEs</description>
          <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3298"/>
                <count group_id="O2" value="3315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2837"/>
                    <measurement group_id="O2" value="2839"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting Any Related AEs</title>
        <description>Number of participants reporting one or more AEs considered related to study drug by the investigator</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Any Related AEs</title>
          <description>Number of participants reporting one or more AEs considered related to study drug by the investigator</description>
          <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3298"/>
                <count group_id="O2" value="3315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="258"/>
                    <measurement group_id="O2" value="298"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting Any Serious Adverse Events (SAEs)</title>
        <description>Number of participants reporting one or more SAEs</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Any Serious Adverse Events (SAEs)</title>
          <description>Number of participants reporting one or more SAEs</description>
          <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3298"/>
                <count group_id="O2" value="3315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="506"/>
                    <measurement group_id="O2" value="485"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting Any Related SAEs</title>
        <description>Number of participants reporting one or more SAEs considered related to study drug by the investigator</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Any Related SAEs</title>
          <description>Number of participants reporting one or more SAEs considered related to study drug by the investigator</description>
          <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3298"/>
                <count group_id="O2" value="3315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting AEs by Highest Severity Grade</title>
        <description>Adverse events events were graded by severity; Level 1, 2, 3, or 4</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting AEs by Highest Severity Grade</title>
          <description>Adverse events events were graded by severity; Level 1, 2, 3, or 4</description>
          <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3298"/>
                <count group_id="O2" value="3315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Level 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1478"/>
                    <measurement group_id="O2" value="1538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1006"/>
                    <measurement group_id="O2" value="976"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="292"/>
                    <measurement group_id="O2" value="271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Level 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Discontinued Study Drug Due to AEs</title>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Discontinued Study Drug Due to AEs</title>
          <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3298"/>
                <count group_id="O2" value="3315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Died</title>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Died</title>
          <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3298"/>
                <count group_id="O2" value="3315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting Changes in Vital Signs From Baseline</title>
        <description>Vital signs that were in a higher toxicity grade than observed at baseline were to be recorded as AEs</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Changes in Vital Signs From Baseline</title>
          <description>Vital signs that were in a higher toxicity grade than observed at baseline were to be recorded as AEs</description>
          <population>The Safety Population included all patients who received any study drug and had any safety follow-up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3298"/>
                <count group_id="O2" value="3315"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fever neonatal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperpyrexia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hyperthermia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypothermia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pyrexia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="559"/>
                    <measurement group_id="O2" value="544"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypotension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arrhythmia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bradycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tachycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Incidence of Outpatient Medically-attended Lower Respiratory Illness (LRI)</title>
        <description>LRI was defined as an event of bronchiolitis or pneumonia or the occurance of a lower tract infectious illness as determined by the PI based on medical history, signs, and symptoms.</description>
        <time_frame>Day 0 - 150</time_frame>
        <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Incidence of Outpatient Medically-attended Lower Respiratory Illness (LRI)</title>
          <description>LRI was defined as an event of bronchiolitis or pneumonia or the occurance of a lower tract infectious illness as determined by the PI based on medical history, signs, and symptoms.</description>
          <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
          <units>Participant</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3306"/>
                <count group_id="O2" value="3329"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="696"/>
                    <measurement group_id="O2" value="648"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A CMH approach stratified by presence or absence of CLD of prematurity requiring medical intervention was used.</non_inferiority_desc>
            <p_value>0.110</p_value>
            <p_value_desc>Test stratified by presence or absence of CLD of prematurity specified on the CRF</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Incidence of RSV-specific Medically-attended Outpatient Lower Respiratory Illnesses (LRIs) Between Treatment Groups</title>
        <description>The RSV-specific LRI was defined as an outpatient medically-attended LRI associated with a positive RSV test and was not inclusive of events that required hospitalization.</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>Subjects were from a pre-specified subsets of sites participating in the nasal secretion sample collection for this endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Incidence of RSV-specific Medically-attended Outpatient Lower Respiratory Illnesses (LRIs) Between Treatment Groups</title>
          <description>The RSV-specific LRI was defined as an outpatient medically-attended LRI associated with a positive RSV test and was not inclusive of events that required hospitalization.</description>
          <population>Subjects were from a pre-specified subsets of sites participating in the nasal secretion sample collection for this endpoint.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1183"/>
                <count group_id="O2" value="1227"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A CMH approach stratified by presence or absence of CLD of prematurity requiring medical intervention was used.</non_inferiority_desc>
            <p_value>0.005</p_value>
            <p_value_desc>No adjustment for multiple comparisons.</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
            <method_desc>The CMH test was stratified by presence or absence of CLD of prematurity as specified on the CRF</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Incidence of Medically-attended Otitis Media (OM) Infections</title>
        <description>Otitis media (OM) was to be recorded as the diagnosis if the following terms were used by the medical care provider: acute OM, acute tympanic membrane (TM) perforation, bulging TM, red TM with fever, OM with effusion, or middle ear effusion. A new episode was defined as a physician-diagnosed OM in either ear after a normal middle ear exam of the ear in question or an episode of acute OM greater than or equal to 21 days after resolution of the previous episode. A diagnosis of persistent middle ear effusion was not to be recorded as a new OM event.</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Incidence of Medically-attended Otitis Media (OM) Infections</title>
          <description>Otitis media (OM) was to be recorded as the diagnosis if the following terms were used by the medical care provider: acute OM, acute tympanic membrane (TM) perforation, bulging TM, red TM with fever, OM with effusion, or middle ear effusion. A new episode was defined as a physician-diagnosed OM in either ear after a normal middle ear exam of the ear in question or an episode of acute OM greater than or equal to 21 days after resolution of the previous episode. A diagnosis of persistent middle ear effusion was not to be recorded as a new OM event.</description>
          <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3306"/>
                <count group_id="O2" value="3329"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Overall incidence</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="461"/>
                    <measurement group_id="O2" value="484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0 infections</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2845"/>
                    <measurement group_id="O2" value="2845"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="329"/>
                    <measurement group_id="O2" value="360"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 infections</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 or more infections</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>P-value is for overall incidence</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A CMH approach stratified by presence or absence of CLD of prematurity requiring medical intervention was used.</non_inferiority_desc>
            <p_value>0.476</p_value>
            <method>Van Eleteren test</method>
            <method_desc>Test stratified by presence or absence of CLD of prematurity specified on the CRF</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Frequency of Prescribed Antibiotics for Medically-attended LRI</title>
        <description>The average number of presciptions per event per subject was summarized for each treatment group.</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Frequency of Prescribed Antibiotics for Medically-attended LRI</title>
          <description>The average number of presciptions per event per subject was summarized for each treatment group.</description>
          <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
          <units>Number of prescriptions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3306"/>
                <count group_id="O2" value="3329"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.32" spread="0.02"/>
                    <measurement group_id="O2" value="0.30" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A CMH approach stratified by presence or absence of CLD of prematurity requiring medical intervention was used.</non_inferiority_desc>
            <p_value>0.493</p_value>
            <p_value_desc>Test stratified by presence or absence of CLD of prematurity specified on the CRF</p_value_desc>
            <method>Van Eleteren test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Frequency of Prescribed Antibiotics for Medically-attended OM Infections</title>
        <description>The average number of presciptions per event per subject was summarized for each treatment group.</description>
        <time_frame>Days 0 - 150</time_frame>
        <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Palivizumab</title>
            <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
          <group group_id="O2">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Frequency of Prescribed Antibiotics for Medically-attended OM Infections</title>
          <description>The average number of presciptions per event per subject was summarized for each treatment group.</description>
          <population>The Intent-to-Treat (ITT) Population included all patients randomized into the study.</population>
          <units>number of prescriptions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3306"/>
                <count group_id="O2" value="3329"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.08" spread="0.003"/>
                    <measurement group_id="O2" value="1.10" spread="0.003"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A CMH approach stratified by presence or absence of CLD of prematurity requiring medical intervention was used.</non_inferiority_desc>
            <p_value>0.652</p_value>
            <p_value_desc>Test stratified by presence or absence of CLD of prematurity specified on the CRF</p_value_desc>
            <method>Van Eleteren test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Number of Participants With Anti-motavizumab Antibodies</title>
        <description>Detection of anti-motavizumab antibodies was defined as a titer with a dilution value equal to or greater than 1:10.</description>
        <time_frame>Day 0 - 120</time_frame>
        <population>N varied at different timepoints: at pre-dose 1 N=3193; at 30 days post-dose 1 N=998; at 30 days post-dose 2 N=1049; at 30 days post-dose 3 N=1049; at 30 days post-dose 4, N=3013; at any time post baseline, N=3217</population>
        <group_list>
          <group group_id="O1">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Participants With Anti-motavizumab Antibodies</title>
          <description>Detection of anti-motavizumab antibodies was defined as a titer with a dilution value equal to or greater than 1:10.</description>
          <population>N varied at different timepoints: at pre-dose 1 N=3193; at 30 days post-dose 1 N=998; at 30 days post-dose 2 N=1049; at 30 days post-dose 3 N=1049; at 30 days post-dose 4, N=3013; at any time post baseline, N=3217</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3217"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-dose 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 Days Post-Dose 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 Days Post-Dose 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 Days Post-Dose 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 Days Post-Dose 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At any time post baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Serum Concentrations of Motavizumab at Day 0</title>
        <description>Mean serum concentrations of motavizumab at Day 0</description>
        <time_frame>Day 0</time_frame>
        <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Serum Concentrations of Motavizumab at Day 0</title>
          <description>Mean serum concentrations of motavizumab at Day 0</description>
          <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug.</population>
          <units>ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3147"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01193" spread="0.2072"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 1</title>
        <description>Mean serum concentrations of motavizumab at 30 days post Dose 1</description>
        <time_frame>30 days post Dose 1</time_frame>
        <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug. Includes subjects with both baseline and a post-dose 1 measurements</population>
        <group_list>
          <group group_id="O1">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 1</title>
          <description>Mean serum concentrations of motavizumab at 30 days post Dose 1</description>
          <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug. Includes subjects with both baseline and a post-dose 1 measurements</population>
          <units>ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="974"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.95" spread="15.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 2</title>
        <description>Mean serum concentrations of motavizumab at 30 days post Dose 2</description>
        <time_frame>30 days post Dose 2</time_frame>
        <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug. Includes subjects with both baseline and a post-dose 2 measurements</population>
        <group_list>
          <group group_id="O1">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 2</title>
          <description>Mean serum concentrations of motavizumab at 30 days post Dose 2</description>
          <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug. Includes subjects with both baseline and a post-dose 2 measurements</population>
          <units>ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="915"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.59" spread="25.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 3</title>
        <description>Mean serum concentrations of motavizumab at 30 days post Dose 3</description>
        <time_frame>30 days post Dose 3</time_frame>
        <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug. Includes subjects with both baseline and a post-dose 3 measurements</population>
        <group_list>
          <group group_id="O1">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 3</title>
          <description>Mean serum concentrations of motavizumab at 30 days post Dose 3</description>
          <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug. Includes subjects with both baseline and a post-dose 3 measurements</population>
          <units>ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="918"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.24" spread="31.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 4</title>
        <description>Mean serum concentrations of motavizumab at 30 days post Dose 4</description>
        <time_frame>30 days post Dose 4</time_frame>
        <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug. Includes subjects with both baseline and a post-dose 4 measurements</population>
        <group_list>
          <group group_id="O1">
            <title>Motavizumab</title>
            <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
          </group>
        </group_list>
        <measure>
          <title>The Trough Serum Concentrations of Motavizumab at 30 Days Post Dose 4</title>
          <description>Mean serum concentrations of motavizumab at 30 days post Dose 4</description>
          <population>The Pharmacokinetics/Immunogenicity (PK/IM) Population included all patients who received study drug and who did not receive non-study commercial palivizumab within 3 months prior to receiving the first dose of study drug. Includes subjects with both baseline and a post-dose 4 measurements</population>
          <units>ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2669"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.52" spread="35.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Day 0 - Day 150</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Palivizumab</title>
          <description>Palivizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
        </group>
        <group group_id="E2">
          <title>Motavizumab</title>
          <description>Motavizumab, 15 mg/kg administered intramuscularly for 5 monthly doses</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 11.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="506" subjects_at_risk="3298"/>
                <counts group_id="E2" subjects_affected="485" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3298"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ANAEMIA NEONATAL</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CYCLIC NEUTROPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HAEMOLYTIC ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HAEMOLYTIC URAEMIC SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>IRON DEFICIENCY ANAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>NEUTROPENIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ATRIAL THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRADYCARDIA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CARDIAC ARREST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE HIGH OUTPUT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CARDIO-RESPIRATORY ARREST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CARDIOGENIC SHOCK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CYANOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>ACRODERMATITIS ENTEROPATHICA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ANAL ATRESIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ANKYLOGLOSSIA CONGENITAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRANCHIAL CLEFT CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CEREBRAL PALSY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CLEFT LIP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CLEFT LIP AND PALATE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CLEFT PALATE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DACRYOSTENOSIS CONGENITAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DERMOID CYST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HAMARTOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HIP DYSPLASIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LIMB REDUCTION DEFECT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PHIMOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PILONIDAL CYST CONGENITAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PYLORIC STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY TRACT MALFORMATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SYNDACTYLY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TALIPES</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="7" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TRACHEO-OESOPHAGEAL FISTULA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VENTRICULAR SEPTAL DEFECT</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>DEAFNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>PAPILLOEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RETINOPATHY OF PREMATURITY</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3298"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RETINOPATHY PROLIFERATIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL DISTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ABDOMINAL STRANGULATED HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ANAL FISTULA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>COLONIC STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DYSPEPSIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DYSPHAGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ENTERITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ENTEROCOLITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ENTEROCUTANEOUS FISTULA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FAECES DISCOLOURED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FLATULENCE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROOESOPHAGEAL REFLUX DISEASE</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="3298"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HIATUS HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ILEUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA</sub_title>
                <counts group_id="E1" events="58" subjects_affected="57" subjects_at_risk="3298"/>
                <counts group_id="E2" events="58" subjects_affected="56" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA, OBSTRUCTIVE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INTUSSUSCEPTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>NECROTISING COLITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL MASS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PANCREATITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RECTAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>REFLUX OESOPHAGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>REGURGITATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>UMBILICAL HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>FEVER NEONATAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HERNIA OBSTRUCTIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPOTHERMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>MALAISE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3298"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SUDDEN DEATH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SUDDEN INFANT DEATH SYNDROME</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CHOLESTASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HEPATIC CYST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPERBILIRUBINAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>DRUG HYPERSENSITIVITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPERSENSITIVITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>IMMUNISATION REACTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>ABSCESS LIMB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ABSCESS NECK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ADENOVIRAL UPPER RESPIRATORY INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BACTERAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BACTERIAL ABSCESS CENTRAL NERVOUS SYSTEM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BACTERIAL PYELONEPHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BACTERIAL TRACHEITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHIOLITIS</sub_title>
                <counts group_id="E1" events="88" subjects_affected="78" subjects_at_risk="3298"/>
                <counts group_id="E2" events="87" subjects_affected="71" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" events="46" subjects_affected="36" subjects_at_risk="3298"/>
                <counts group_id="E2" events="39" subjects_affected="35" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHITIS VIRAL</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHOPNEUMONIA</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3298"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CATHETER SEPSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CENTRAL LINE INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIAL INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CROUP INFECTIOUS</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="3298"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CYTOMEGALOVIRUS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DACRYOCYSTITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DYSENTERY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ENTEROBACTER BACTERAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ENTEROCOLITIS VIRAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>EXANTHEMA SUBITUM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>EXTERNAL EAR CELLULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="31" subjects_affected="31" subjects_at_risk="3298"/>
                <counts group_id="E2" events="28" subjects_affected="27" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS ADENOVIRUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS ESCHERICHIA COLI</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS ROTAVIRUS</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="3298"/>
                <counts group_id="E2" events="15" subjects_affected="13" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS SALMONELLA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HERPES ZOSTER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>IMPETIGO</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LARYNGITIS</sub_title>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="3298"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LOBAR PNEUMONIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LOWER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3298"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LOWER RESPIRATORY TRACT INFECTION VIRAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LUNG ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LYMPHADENITIS BACTERIAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>MENINGITIS VIRAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ORAL CANDIDIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OTITIS MEDIA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OTITIS MEDIA BACTERIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PARAINFLUENZAE VIRUS INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PERTUSSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PHARYNGOTONSILLITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="31" subjects_affected="31" subjects_at_risk="3298"/>
                <counts group_id="E2" events="28" subjects_affected="27" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA ADENOVIRAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA BACTERIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA BORDETELLA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA INFLUENZAL</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA PARAINFLUENZAE VIRAL</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA VIRAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE WOUND INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS</sub_title>
                <counts group_id="E1" events="43" subjects_affected="40" subjects_at_risk="3298"/>
                <counts group_id="E2" events="25" subjects_affected="25" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SYNCYTIAL VIRUS INFECTION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY TRACT INFECTION VIRAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RHINITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ROTAVIRUS INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TRACHEITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TRACHEOBRONCHITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="3298"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3298"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION BACTERIAL</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION ENTEROCOCCAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION PSEUDOMONAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>UROSEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VARICELLA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3298"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VIRAL RHINITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VIRAL UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>CHILD MALTREATMENT SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DEVICE MALFUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FACE INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FEEDING TUBE COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FOREIGN BODY TRAUMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HAIR-THREAD TOURNIQUET SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HEAD INJURY</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>MEDICAL DEVICE COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL DISCHARGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SHUNT MALFUNCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SKULL FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SUBDURAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TRAUMATIC BRAIN INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VENTRICULOPERITONEAL SHUNT MALFUNCTION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VIIITH NERVE INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BIOPSY RECTUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BLOOD BILIRUBIN INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CYSTOGRAM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FALSE POSITIVE LABORATORY RESULT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HEPATIC ENZYME INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INVESTIGATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LIVER FUNCTION TEST ABNORMAL</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>MEDICAL OBSERVATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>NEUROLOGICAL EXAMINATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL PH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OXYGEN SATURATION DECREASED</sub_title>
                <counts group_id="E1" events="5" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PHYSICAL EXAMINATION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>WEIGHT DECREASED</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>ANOREXIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>COW'S MILK INTOLERANCE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FAILURE TO THRIVE</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3298"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FEEDING DISORDER OF INFANCY OR EARLY CHILDHOOD</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FLUID INTAKE REDUCED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FLUID OVERLOAD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPERCALCAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPERNATRAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LACTOSE INTOLERANCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>MALNUTRITION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>WEIGHT GAIN POOR</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ZINC DEFICIENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>CRANIOSYNOSTOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>MUSCLE CONTRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OSTEOPENIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>HAEMANGIOMA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3298"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>ALTERED STATE OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CEREBRAL VENTRICLE DILATATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CONVULSION</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3298"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CONVULSION NEONATAL</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ENCEPHALITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>EPILEPSY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FEBRILE CONVULSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE INTRACRANIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYDROCEPHALUS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPERTONIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPOXIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INTRACRANIAL PRESSURE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LETHARGY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>MYOCLONUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SOMNOLENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SYNCOPE VASOVAGAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VOCAL CORD PARESIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>BREATH HOLDING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESTLESSNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>URETERIC STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>BALANITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OVARIAN CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SCROTAL OEDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>APNOEA</sub_title>
                <counts group_id="E1" events="23" subjects_affected="17" subjects_at_risk="3298"/>
                <counts group_id="E2" events="16" subjects_affected="14" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>APPARENT LIFE THREATENING EVENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ASPIRATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3298"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ATELECTASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHIAL HYPERREACTIVITY</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="3298"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHOPNEUMOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHOPULMONARY DYSPLASIA</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="3298"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHOSPASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CHOKING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FOREIGN BODY ASPIRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPOVENTILATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPOXIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INTERSTITIAL LUNG DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LARYNGEAL OEDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LARYNGEAL STENOSIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LARYNGOSPASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LUNG CONSOLIDATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>NASAL CONGESTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OBSTRUCTIVE AIRWAYS DISORDER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PHARYNGEAL INFLAMMATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA ASPIRATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMOTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PULMONARY CONGESTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PULMONARY HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PULMONARY HYPERTENSION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PULMONARY HYPERTENSIVE CRISIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DISTRESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SLEEP APNOEA SYNDROME</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>STATUS ASTHMATICUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>STRIDOR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TACHYPNOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TONSILLAR HYPERTROPHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VOCAL CORD DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>WHEEZING</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ANGIOEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PETECHIAE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>URTICARIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>SOCIAL STAY HOSPITALISATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VICTIM OF CHILD ABUSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>CENTRAL VENOUS CATHETERISATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>COLOSTOMY CLOSURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>EAR TUBE INSERTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROSTOMY CLOSURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROSTOMY TUBE INSERTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ILEOSTOMY CLOSURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>NUTRITIONAL SUPPORT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VENTRICULO-PERITONEAL SHUNT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="3298"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>MedDRA 11.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2777" subjects_at_risk="3298"/>
                <counts group_id="E2" subjects_affected="2784" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="75" subjects_affected="73" subjects_at_risk="3298"/>
                <counts group_id="E2" events="67" subjects_affected="66" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>DACRYOSTENOSIS CONGENITAL</sub_title>
                <counts group_id="E1" events="34" subjects_affected="33" subjects_at_risk="3298"/>
                <counts group_id="E2" events="37" subjects_affected="35" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>CONJUNCTIVITIS</sub_title>
                <counts group_id="E1" events="285" subjects_affected="251" subjects_at_risk="3298"/>
                <counts group_id="E2" events="271" subjects_affected="246" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="73" subjects_affected="70" subjects_at_risk="3298"/>
                <counts group_id="E2" events="55" subjects_affected="54" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="262" subjects_affected="227" subjects_at_risk="3298"/>
                <counts group_id="E2" events="265" subjects_affected="234" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="306" subjects_affected="274" subjects_at_risk="3298"/>
                <counts group_id="E2" events="295" subjects_affected="254" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>FLATULENCE</sub_title>
                <counts group_id="E1" events="135" subjects_affected="119" subjects_at_risk="3298"/>
                <counts group_id="E2" events="170" subjects_affected="126" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROOESOPHAGEAL REFLUX DISEASE</sub_title>
                <counts group_id="E1" events="198" subjects_affected="190" subjects_at_risk="3298"/>
                <counts group_id="E2" events="197" subjects_affected="190" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>TEETHING</sub_title>
                <counts group_id="E1" events="408" subjects_affected="282" subjects_at_risk="3298"/>
                <counts group_id="E2" events="417" subjects_affected="299" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>UMBILICAL HERNIA</sub_title>
                <counts group_id="E1" events="63" subjects_affected="63" subjects_at_risk="3298"/>
                <counts group_id="E2" events="77" subjects_affected="77" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="179" subjects_affected="164" subjects_at_risk="3298"/>
                <counts group_id="E2" events="174" subjects_affected="158" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>INJECTION SITE ERYTHEMA</sub_title>
                <counts group_id="E1" events="38" subjects_affected="28" subjects_at_risk="3298"/>
                <counts group_id="E2" events="52" subjects_affected="41" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>INJECTION SITE PAIN</sub_title>
                <counts group_id="E1" events="94" subjects_affected="49" subjects_at_risk="3298"/>
                <counts group_id="E2" events="81" subjects_affected="45" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>IRRITABILITY</sub_title>
                <counts group_id="E1" events="243" subjects_affected="164" subjects_at_risk="3298"/>
                <counts group_id="E2" events="299" subjects_affected="193" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" events="729" subjects_affected="556" subjects_at_risk="3298"/>
                <counts group_id="E2" events="718" subjects_affected="543" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>IMMUNISATION REACTION</sub_title>
                <counts group_id="E1" events="122" subjects_affected="97" subjects_at_risk="3298"/>
                <counts group_id="E2" events="138" subjects_affected="102" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>BRONCHIOLITIS</sub_title>
                <counts group_id="E1" events="263" subjects_affected="222" subjects_at_risk="3298"/>
                <counts group_id="E2" events="226" subjects_affected="193" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" events="356" subjects_affected="260" subjects_at_risk="3298"/>
                <counts group_id="E2" events="328" subjects_affected="230" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>CANDIDIASIS</sub_title>
                <counts group_id="E1" events="93" subjects_affected="79" subjects_at_risk="3298"/>
                <counts group_id="E2" events="65" subjects_affected="58" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="223" subjects_affected="207" subjects_at_risk="3298"/>
                <counts group_id="E2" events="212" subjects_affected="199" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" events="36" subjects_affected="32" subjects_at_risk="3298"/>
                <counts group_id="E2" events="40" subjects_affected="40" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>LOWER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="165" subjects_affected="133" subjects_at_risk="3298"/>
                <counts group_id="E2" events="159" subjects_affected="130" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="333" subjects_affected="262" subjects_at_risk="3298"/>
                <counts group_id="E2" events="325" subjects_affected="240" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ORAL CANDIDIASIS</sub_title>
                <counts group_id="E1" events="120" subjects_affected="107" subjects_at_risk="3298"/>
                <counts group_id="E2" events="113" subjects_affected="101" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OTITIS MEDIA</sub_title>
                <counts group_id="E1" events="565" subjects_affected="418" subjects_at_risk="3298"/>
                <counts group_id="E2" events="575" subjects_affected="432" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>OTITIS MEDIA ACUTE</sub_title>
                <counts group_id="E1" events="79" subjects_affected="54" subjects_at_risk="3298"/>
                <counts group_id="E2" events="83" subjects_affected="65" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS</sub_title>
                <counts group_id="E1" events="101" subjects_affected="91" subjects_at_risk="3298"/>
                <counts group_id="E2" events="81" subjects_affected="70" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="39" subjects_affected="35" subjects_at_risk="3298"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RHINITIS</sub_title>
                <counts group_id="E1" events="593" subjects_affected="444" subjects_at_risk="3298"/>
                <counts group_id="E2" events="600" subjects_affected="440" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1482" subjects_affected="981" subjects_at_risk="3298"/>
                <counts group_id="E2" events="1420" subjects_affected="956" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="112" subjects_affected="98" subjects_at_risk="3298"/>
                <counts group_id="E2" events="103" subjects_affected="86" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>VIRAL UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="64" subjects_affected="60" subjects_at_risk="3298"/>
                <counts group_id="E2" events="64" subjects_affected="56" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BLOOD UREA INCREASED</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="3298"/>
                <counts group_id="E2" events="35" subjects_affected="35" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>HAEMANGIOMA</sub_title>
                <counts group_id="E1" events="41" subjects_affected="38" subjects_at_risk="3298"/>
                <counts group_id="E2" events="34" subjects_affected="29" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>AGITATION</sub_title>
                <counts group_id="E1" events="61" subjects_affected="47" subjects_at_risk="3298"/>
                <counts group_id="E2" events="51" subjects_affected="35" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" events="45" subjects_affected="37" subjects_at_risk="3298"/>
                <counts group_id="E2" events="37" subjects_affected="33" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>BRONCHIAL HYPERREACTIVITY</sub_title>
                <counts group_id="E1" events="62" subjects_affected="54" subjects_at_risk="3298"/>
                <counts group_id="E2" events="48" subjects_affected="44" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="262" subjects_affected="216" subjects_at_risk="3298"/>
                <counts group_id="E2" events="260" subjects_affected="220" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>NASAL CONGESTION</sub_title>
                <counts group_id="E1" events="326" subjects_affected="265" subjects_at_risk="3298"/>
                <counts group_id="E2" events="318" subjects_affected="269" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DISORDER</sub_title>
                <counts group_id="E1" events="374" subjects_affected="275" subjects_at_risk="3298"/>
                <counts group_id="E2" events="380" subjects_affected="295" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RHINORRHOEA</sub_title>
                <counts group_id="E1" events="112" subjects_affected="92" subjects_at_risk="3298"/>
                <counts group_id="E2" events="124" subjects_affected="99" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>WHEEZING</sub_title>
                <counts group_id="E1" events="85" subjects_affected="70" subjects_at_risk="3298"/>
                <counts group_id="E2" events="61" subjects_affected="51" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>DERMATITIS ATOPIC</sub_title>
                <counts group_id="E1" events="55" subjects_affected="53" subjects_at_risk="3298"/>
                <counts group_id="E2" events="48" subjects_affected="44" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DERMATITIS DIAPER</sub_title>
                <counts group_id="E1" events="233" subjects_affected="192" subjects_at_risk="3298"/>
                <counts group_id="E2" events="199" subjects_affected="177" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>DRY SKIN</sub_title>
                <counts group_id="E1" events="26" subjects_affected="25" subjects_at_risk="3298"/>
                <counts group_id="E2" events="37" subjects_affected="35" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>ECZEMA</sub_title>
                <counts group_id="E1" events="100" subjects_affected="95" subjects_at_risk="3298"/>
                <counts group_id="E2" events="140" subjects_affected="132" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" events="110" subjects_affected="103" subjects_at_risk="3298"/>
                <counts group_id="E2" events="147" subjects_affected="130" subjects_at_risk="3315"/>
              </event>
              <event>
                <sub_title>SEBORRHOEIC DERMATITIS</sub_title>
                <counts group_id="E1" events="53" subjects_affected="52" subjects_at_risk="3298"/>
                <counts group_id="E2" events="57" subjects_affected="56" subjects_at_risk="3315"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>M. Pamela Griffin, Sr. Director, Clinical Development</name_or_title>
      <organization>MedImmune</organization>
      <phone>301-398-0000</phone>
      <email>clinicaltrialenquiries@medimmune.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

